![]()
|
|
||||||||
J. Biol. Chem., Vol. 263, Issue 30, 15313-15318, 10, 1988
J Pieters, G Willems, HC Hemker and T Lindhout
We investigated the kinetics of the inhibitory action of antithrombin III
and antithrombin III plus heparin during the activation of factor X by
factor IXa. Generation and inactivation curves were fitted to a
three-parameter two-exponentional model to determine the pseudo first-
order rate constants of inhibition of factor IXa and factor Xa by
antithrombin III/heparin. In the absence of heparin, the second-order rate
constant of inhibition of factor Xa generated by factor IXa was 2.5-fold
lower than the rate constant of inhibition of exogenous factor Xa. It
appeared that phospholipid-bound factor X protected factor Xa from
inactivation by antithrombin III. It is, as yet, unclear whether an active
site or a nonactive site interaction between factor Xa and factor X at the
phospholipid surface is involved. The inactivation of factor IXa by
antithrombin III was found to be very slow and was not affected by
phospholipid, calcium, and/or factor X. With unfractionated heparin above
40 ng/ml and antithrombin III at 200 nM, the apparent second-order rate
constant of inhibition of exogenous and generated factor Xa were the same.
Thus, in this case phospholipid-bound factor X did not protect factor Xa
from inhibition. In the presence of synthetic pentasaccharide heparin,
however, phospholipid-bound factor X reduced the rate constant about
5-fold. Pentasaccharide had no effect on the factor IXa/antithrombin III
reaction. Unfractionated heparin (1 micrograms/ml) stimulated the
antithrombin III-dependent inhibition of factor IXa during factor X
activation 400-fold. In the absence of reaction components this stimulated
was 65-fold. We established that calcium stimulated the heparin-dependent
inhibition of factor IXa.
Inhibition of factor IXa and factor Xa by antithrombin III/heparin during factor X activation
Department of Biochemistry, University of Limburg, Maastricht, The Netherlands.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
E. M. Wiebe, A. R. Stafford, J. C. Fredenburgh, and J. I. Weitz Mechanism of Catalysis of Inhibition of Factor IXa by Antithrombin in the Presence of Heparin or Pentasaccharide J. Biol. Chem., September 12, 2003; 278(37): 35767 - 35774. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Dickneite and B. Leithauser Influence of Antithrombin III on Coagulation and Inflammation in Porcine Septic Shock Arterioscler. Thromb. Vasc. Biol., June 1, 1999; 19(6): 1566 - 1572. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Samis, E. Kam, M. E. Nesheim, and A. R. Giles Neutrophil Elastase Cleavage of Human Factor IX Generates an Activated Factor IX-Like Product Devoid of Coagulant Function Blood, August 15, 1998; 92(4): 1287 - 1296. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Iverson and U. Abildgaard State-of-the-Art Review : Role of Antithrombin and Tissue Factor Pathway Inhibitor in the Control of Thrombosis and Mediation of Heparin Action Clinical and Applied Thrombosis/Hemostasis, January 1, 1996; 2(1): 1 - 6. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |